Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)
China flag China · Delayed Price · Currency is CNY
7.59
-0.10 (-1.30%)
Nov 6, 2026, 11:55 AM CST

SHE:002873 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
693.68748.82856.87953.261,087968.7
Other Revenue
0.90.90.670.730.881.15
694.58749.72857.55953.981,088969.84
Revenue Growth
-8.04%-12.57%-10.11%-12.29%12.15%29.15%
Cost of Revenue
195.03216.67230.72219.39247.65201.16
Gross Profit
499.55533.05626.83734.59840.02768.69
Selling, General & Admin
427.93456.71513.64589.02673.99606.18
Research & Development
39.6742.5540.4738.1321.5820.38
Other Operating Expenses
10.3512.311210.5413.1713.81
Operating Expenses
477.93510.19568.72637.42709.27642.1
Operating Income
21.6222.8658.1197.17130.75126.58
Interest Expense
-5.23-17.76-17.57-11.8-10.67-16.6
Interest & Investment Income
0.260.420.670.920.731.37
Currency Exchange Gain (Loss)
---0--
Other Non Operating Income (Expenses)
-100.31-0.051.92-5.41-2.93
EBT Excluding Unusual Items
6.665.8341.1688.21115.39108.42
Gain (Loss) on Sale of Investments
-0.04-0.020.02-0.72-0.4-
Gain (Loss) on Sale of Assets
3.62-0.7818.9--0.02-0.1
Asset Writedown
0.13-0.16-0.71-0.07-0.12-0.37
Other Unusual Items
0.584.91.3856.488.69
Pretax Income
10.959.7760.7692.42121.34116.65
Income Tax Expense
1.310.668.4311.559.8316.04
Earnings From Continuing Operations
9.649.1152.3280.87111.52100.61
Net Income
9.649.1152.3280.87111.52100.61
Net Income to Common
9.649.1152.3280.87111.52100.61
Net Income Growth
28.41%-82.59%-35.30%-27.48%10.85%35.76%
Shares Outstanding (Basic)
230235220232232227
Shares Outstanding (Diluted)
230235220245244245
Shares Change
-0.33%6.87%-9.91%0.41%-0.41%1.34%
EPS (Basic)
0.040.040.240.350.480.44
EPS (Diluted)
0.040.040.240.330.460.41
EPS Growth
28.84%-83.70%-28.18%-27.78%11.30%33.96%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
78.2432.1426.68-23.92-53.3818.61
Free Cash Flow Per Share
0.340.140.12-0.10-0.220.08
Dividend Per Share
0.0300.0300.1000.0700.1000.086
Dividend Growth
-50.00%-70.00%42.86%-30.00%16.69%40.03%
Gross Margin
71.92%71.10%73.10%77.00%77.23%79.26%
Operating Margin
3.11%3.05%6.78%10.19%12.02%13.05%
Profit Margin
1.39%1.21%6.10%8.48%10.25%10.37%
Free Cash Flow Margin
11.27%4.29%3.11%-2.51%-4.91%1.92%
EBITDA
54.9455.7490.4117.51155.38148.33
EBITDA Margin
7.91%7.43%10.54%12.32%14.29%15.29%
D&A For EBITDA
33.3232.8832.2920.3424.6421.74
EBIT
21.6222.8658.1197.17130.75126.58
EBIT Margin
3.11%3.05%6.78%10.19%12.02%13.05%
Effective Tax Rate
11.97%6.73%13.88%12.49%8.10%13.75%
Revenue as Reported
191.09749.72857.55953.981,088969.84
Advertising Expenses
-13.0916.5743.4643.15-